Skip to main content
Premium Trial:

Request an Annual Quote

Going for Broke

Biotechs are running out of cash, reports the Wall Street Journal. (OK, you probably already knew that.) In the past four months, 10 biotechs have gone bankrupt and, currently, 120 of the 360 publicly traded companies have less than six months' worth of cash -- the Journal's Health blog speculates that no one will be able to support the small biotechs. One company that the main article points to is Helicos Biosciences, saying that "even blue-ribbon scientific credentials are no guarantee of business success," as Helicos has struggled with a lack of sales and, last year, nearly running out of money.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.